Bayer stops blood thinner drug trial for lack of effect in major setback, World News - AsiaOne
Descrição
Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion
Too big to fail: 4 insurers to face higher standards and scrutiny under new MAS rule, Money News - AsiaOne
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FIMW37L37ZNYBB5IODUPLT47GU.jpg)
Bayer woes pile up as blood thinner drug trial fails
Bayer stops blood thinner drug trial for lack of effect in major setback
Japan companies punished over dodgy 'antibacterial' labels, Health News - AsiaOne
Biden not surprised by report of Wagner boss Yevgeny Prigozhin's death, World News - AsiaOne
Germany surpasses 100,000 daily Covid-19 cases for first time, World News - AsiaOne
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IY2AUX33MJON3LKGKZOBW3HLZA.jpg)
Bayer gets FDA fast track status for next-generation blood thinner
Bayer woes pile up as blood thinner drug trial fails
Qualitas To Provide COVID-19 Mobile Home Sampling, Business News - AsiaOne
Duchess Meghan sought advice from senior royals before writing letter to father, World News - AsiaOne
de
por adulto (o preço varia de acordo com o tamanho do grupo)
